Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-EN
Language French English
Date Updated 2019-11-06 2019-11-06
Drug Identification Number 02170493 02170493
Brand name LEDERLE LEUCOVORIN LEDERLE LEUCOVORIN
Common or Proper name LEDERLE LEUCOVORIN LEDERLE LEUCOVORIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LEUCOVORIN LEUCOVORIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 24 24
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-11-18 2019-11-18
Actual start date
Estimated end date 2019-11-28 2019-11-28
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments Other presentations remain available. Other presentations remain available.
Health Canada comments